The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Buserelin treatment to rats causes enteric neurodegeneration with moderate effects on CRF-immunoreactive neurons and Enterobacteriaceae in colon, and in acetylcholine-mediated permeability in ileum.

Author

Summary, in English

The gonadotropin-releasing hormone (GnRH) analog buserelin causes enteric neuronal loss. Acute stress or injection of corticotropin-releasing factor (CRF) affects motility, secretion, and barrier function of the gastrointestinal tract. The aim of the study was to characterize the CRF immunoreactivity in enteric neurons after buserelin treatment, and to evaluate possible effects of enteric neuropathy on gut microbiota, intestinal permeability, and stress response behavior.

Department/s

Publishing year

2015

Language

English

Publication/Series

BMC Research Notes

Volume

8

Issue

1

Document type

Journal article

Publisher

BioMed Central (BMC)

Topic

  • Gastroenterology and Hepatology

Status

Published

Research group

  • Neurogastroenterology
  • Clinical Coagulation, Malmö
  • Gastroenterology
  • Chronic Inflammatory and Degenerative Diseases Research Unit
  • Internal Medicine - Epidemiology

ISBN/ISSN/Other

  • ISSN: 1756-0500